Perceptra Receives Health Sciences Authority (HSA) Approval for Inspectra CXR

Perceptra, a Thai Healthtech Startup, today announced that our AI for chest X-ray analysis, Inspectra CXR has received official approval from the Health Sciences Authority (HSA) of Singapore.

About Inspectra CXR

Inspectra CXR is AI-based software that analyzes adult frontal chest X-rays for signs of abnormalities in order to prioritize them for clinical review. This software aims to assist the interpretation of chest x-ray images for radiologists.

Inspectra CXR previously received approval from the Thai FDA and has been successfully implemented in hospitals across Thailand. This Singapore HSA approval signifies Perceptra’s commitment to expanding its reach and providing innovative AI solutions for medical imaging throughout Southeast Asia.

“We are dedicated to developing AI solutions that can benefit healthcare not only in Thailand but across the regions especially countries in Southeast Asia who face with similar pains such as shortage of healthcare personnels and accessibility,” said Supitchaya Phupisut, CEO at Perceptra.

“The field of AI-powered medical imaging is still maturing in Thailand,” Chaiwat Phupisut, COO at Perceptra, explained. “This is why we prioritize obtaining regulatory approvals. Healthcare providers deserve complete trust in the software they use, and Perceptra is dedicated to earning that trust.”

With these approvals in hand, we remain dedicated to developing AI solutions for medical imaging that contribute to healthcare improvements in Thailand and across Southeast Asia.

Facebook
Twitter
LinkedIn

Related Resources

A real clinical case showing how Inspectra CXR flagged a Stage I lung cancer that migjt missed on initial review. Learn how AI supports radiologists in health checkup workflows.
Every film sat in the same undifferentiated queue, whether it showed a healthy lung or an advanced TB infection. AI triage didn't solve the staffing shortage, but it solved the workflow.
Perceptra has been selected as a technology partner for the launch of the A.Catalyst Network Thailand Hub by AstraZeneca (Thailand), joining a global health innovation network active in more than 20 countries. This selection marks a significant recognition of Thai-developed artificial intelligence on the international stage.